{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:37:35Z","timestamp":1786995455335,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008997","name":"Sociedad Andaluza de Neurolog\u00eda","doi-asserted-by":"publisher","award":["SUBAIA2015\/006"],"award-info":[{"award-number":["SUBAIA2015\/006"]}],"id":[{"id":"10.13039\/501100008997","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014028","name":"H2020","doi-asserted-by":"publisher","award":["EULACH16\/T010131"],"award-info":[{"award-number":["EULACH16\/T010131"]}],"id":[{"id":"10.13039\/100014028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PI19\/01577"],"award-info":[{"award-number":["PI19\/01577"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andalucia","doi-asserted-by":"publisher","award":["BIO127"],"award-info":[{"award-number":["BIO127"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CPII17\/00024"],"award-info":[{"award-number":["CPII17\/00024"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD16\/0017\/0001"],"award-info":[{"award-number":["RD16\/0017\/0001"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.parkreldis.2021.05.014","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T22:12:32Z","timestamp":1621980752000},"page":"3-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["ATP13A2 levels in serum and cerebrospinal fluid in patients with idiopathic Parkinson's disease"],"prefix":"10.1016","volume":"88","author":[{"given":"Emilio","family":"Fern\u00e1ndez-Espejo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4516-5795","authenticated-orcid":false,"given":"Fernando","family":"Rodriguez de Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro","family":"Gonz\u00e1lez-Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3846-556X","authenticated-orcid":false,"given":"Ana","family":"Santurt\u00fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 6","key":"10.1016\/j.parkreldis.2021.05.014_bib1","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/mds.10557","article-title":"Neuropathological spectrum of synucleinopathies","volume":"18","author":"Jellinger","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.05.014_bib2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(14)61010-2","article-title":"Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives","volume":"384","author":"Schapira","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2021.05.014_bib3","doi-asserted-by":"crossref","first-page":"9611","DOI":"10.1073\/pnas.1112368109","article-title":"Loss of P-type ATPase ATP13A2\/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration","volume":"109","author":"Dehay","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.parkreldis.2021.05.014_bib4","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.nbd.2011.12.015","article-title":"ATP13A2 regulates mitochondrial bioenergetics through macroautophagy","volume":"45","author":"Gusdon","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.parkreldis.2021.05.014_bib5","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/hmg\/ddr606","article-title":"PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity","volume":"21","author":"Ramonet","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.parkreldis.2021.05.014_bib6","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/hmg\/ddt057","article-title":"Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited \u03b1-synuclein accumulation and age-dependent sensorimotor deficits","volume":"22","author":"Schultheis","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.parkreldis.2021.05.014_bib7","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1093\/hmg\/ddu099","article-title":"Parkinson's disease-linked human PARK9\/ATP13A2 maintains zinc homeostasis and promotes \u03b1-Synuclein externalization via exosomes","volume":"23","author":"Kong","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.parkreldis.2021.05.014_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/2051-5960-1-11","article-title":"ATP13A2 (PARK9) protein levels are reduced in brain tissue of cases with Lewy bodies","volume":"1","author":"Murphy","year":"2013","journal-title":"Acta Neuropathol. Comm."},{"key":"10.1016\/j.parkreldis.2021.05.014_bib9","doi-asserted-by":"crossref","first-page":"314","DOI":"10.5607\/en.2014.23.4.314","article-title":"ATP13A2 and alpha-synuclein: a metal taste in autophagy","volume":"23","author":"Lopes da Fonseca","year":"2014","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.parkreldis.2021.05.014_bib10","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ng1884","article-title":"Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase","volume":"38","author":"Ramirez","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.parkreldis.2021.05.014_bib11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jprot.2010.11.010","article-title":"Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics","volume":"74","author":"Kroksveen","year":"2011","journal-title":"J. Proteomics"},{"key":"10.1016\/j.parkreldis.2021.05.014_bib12","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00702-012-0784-0","article-title":"\u03b1-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system","volume":"119","author":"Mollenhauer","year":"2012","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.parkreldis.2021.05.014_bib13","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/mds.27232","article-title":"Fox investigation of new biomarker discovery, cerebrospinal fluid, plasma, and saliva in the BioFIND study: relationships among biomarkers and Parkinson's disease features","volume":"33","author":"Goldman","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.05.014_bib14","first-page":"2","article-title":"Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder, N.P","volume":"5","author":"Chahine","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.parkreldis.2021.05.014_bib15","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/aab799","article-title":"Optimization of the reconstruction parameters in [(123)I]FP-CIT SPECT","volume":"63","author":"Ni\u00f1erola-Baiz\u00e1n","year":"2018","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.parkreldis.2021.05.014_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/mdc3.12000","article-title":"Advances in the genetics of Parkinson's disease: a guide for the clinician","volume":"1","author":"Sheerin","year":"2014","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.parkreldis.2021.05.014_bib17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.exger.2018.05.009","article-title":"Analysis of neurotrophic and antioxidant factors related to midbrain dopamine neuronal loss and brain inflammation in the cerebrospinal fluid of the elderly","volume":"110","author":"Martin-de-Pablos","year":"2018","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.parkreldis.2021.05.014_bib18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000071193","article-title":"A case-control study on cigarette, alcohol, and coffee consumption preceding Parkinson's disease","volume":"22","author":"Ragonese","year":"2003","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.parkreldis.2021.05.014_bib19","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson's disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov. Disord."},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2021.05.014_bib20","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/jnc.13390","article-title":"Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders","volume":"139","author":"Mollenhauer","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.parkreldis.2021.05.014_bib21","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrn2471","article-title":"Molecular mechanisms of L-DOPA-induced dyskinesia","volume":"9","author":"Jenner","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"issue":"suppl 4","key":"10.1016\/j.parkreldis.2021.05.014_bib22","first-page":"S1","article-title":"The scientific and clinical basis for the treatment of Parkinson's disease","volume":"72","author":"Olanow","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2021.05.014_bib23","first-page":"CD007166","article-title":"Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson's disease patients with motor complications","author":"Stowe","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.parkreldis.2021.05.014_bib24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.nbd.2003.10.003","article-title":"Plasma and CSF markers of oxidative stress are increased in Parkinson's disease and influenced by antiparkinsonian medication","volume":"15","author":"Buhmann","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.parkreldis.2021.05.014_bib25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.nbd.2008.11.011","article-title":"Increased oxidative damage in peripheral blood correlates with severity of Parkinson's disease","volume":"33","author":"Chen","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.parkreldis.2021.05.014_bib26","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/mds.26005","article-title":"Endothelial dysfunction and hyperhomocysteinemia in Parkinson's disease: flow-mediated dilation study","volume":"29","author":"Yoon","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.05.014_bib27","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.expneurol.2014.08.019","article-title":"Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease. Involvement of vascular endothelial growth factor and interleukin-1\u03b2","volume":"261","author":"Mu\u00f1oz","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.parkreldis.2021.05.014_bib28","first-page":"369","article-title":"Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease","volume":"8","author":"Jim\u00e9nez-Jim\u00e9nez","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.parkreldis.2021.05.014_bib29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/ane.12590","article-title":"Cerebrospinal fluid biomarkers for Parkinson's disease - a systematic review","volume":"135","author":"Andersen","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.parkreldis.2021.05.014_bib30","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","article-title":"CSF and blood biomarkers for Parkinson's disease","volume":"18","author":"Parnetti","year":"2019","journal-title":"Lancet Neurol."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021001851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021001851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:39:23Z","timestamp":1778600363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802021001851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":30,"alternative-id":["S1353802021001851"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.05.014","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ATP13A2 levels in serum and cerebrospinal fluid in patients with idiopathic Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}